Yes. John Boozman disclosed 2 purchases and 1 sale of Eli Lilly (LLY) stock between Aug 11, 2025 and Nov 21, 2025, in STOCK Act reports. Added together, the disclosed purchases come to $2K-$30K and the disclosed sales to $1K-$15K.
Yes. John Boozman disclosed 2 purchases and 1 sale of Eli Lilly (LLY) stock between Aug 11, 2025 and Nov 21, 2025, in STOCK Act reports. Added together, the disclosed purchases come to $2K-$30K and the disclosed sales to $1K-$15K.
How big were John Boozman's Eli Lilly trades?
STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed purchases come to $2K-$30K and the disclosed sales to $1K-$15K.
Did John Boozman make these Eli Lilly trades personally?
Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.
Does John Boozman still own Eli Lilly stock?
This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.
When did John Boozman report these trades?
The latest filing is dated Dec 8, 2025. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.
Where does this data come from?
From periodic transaction reports filed under the STOCK Act with the Secretary of the Senate. Every trade links to the original filing.
Loading